— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.9% 1M: +130.0% 3M: -39.6% YTD: -41.4% 1Y: -43.2% 3Y: -71.8% 5Y: -85.1%
$4.91
-0.31 (-5.94%)
 
Weekly Expected Move ±31.0%
$2 $4 $5 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 60 · $405.4M mcap · 76M float · 9.36% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
-$192M -3.7% ▼
Capital Expenditures
$7M -18.1% ▼
5Y CAGR: +0.4%
Free Cash Flow
-$199M -4.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$37M +150.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$81M-$118M-$174M-$216M-$247M
Depreciation & Amort.$2M$2M$2M$3M$4M
Stock-Based Comp.$12M$24M$28M$34M$35M
Change in Working Capital$4M$7M$15M$5M$24M
Other Non-Cash Items$2M$2M$494K-$12M-$8M
Operating Cash Flow-$61M-$82M-$128M-$185M-$192M
— Investing Activities —
Capital Expenditures-$2M-$2M-$2M-$6M-$7M
Acquisitions (Net)$0-$530$140K$0$0
Investment Purchases-$392M-$256M-$583M-$490M-$404M
Investment Sales$206M$256M$443M$592M$386M
Other Investing$0$530-$140K$0$0
Investing Cash Flow-$189M-$2M-$143M$97M-$24M
— Financing Activities —
Net Debt Issuance-$10M-$264K$28M$15M-$599K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$96M$0$96M$0$97M
Financing Cash Flow$372M$7M$311M$16M$252M
Net Change in Cash$123M-$77M$41M-$72M$37M
Cash End of Period$184M$108M$148M$76M$113M
Free Cash Flow-$64M-$85M-$130M-$191M-$199M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms